We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Sandra and Edward Meyer Cancer Center

Warning message

The subscription service is currently unavailable. Please try again later.

You are here


Selina Chen-Kiang, Ph.D., Receives Funding from the Leukemia & Lymphoma Society's New Research Program

Monday, January 8, 2018

Selina Chen-Kiang, Ph.D., is the recipient of a grant from the Leukemia & Lymphoma Society's new research program in Mantle Cell Lymphoma (MCL). She and her team investigate the efficacy of a therapy approved for breast cancer for the treatment of MCL patients. Small studies have shown promise, either alone or in combination with ibrutinib, which is already already approved for MCL. However, many patients are resistant or relapse, and the team will try to understand why, and whether adding a therapy that boosts the immune system might help.

Read the full press release here: http://www.lls.org/lls-us-hq/news/lls-announces-new-research-program-for...

Also, check out the recent Q & A with Dr. Chen-Kiang at WCM Central: https://wcmcentral.weill.cornell.edu/news/q-dr-selina-chen-kiang